DSS Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. DSS is led by its seasoned leaders with decades of industry experience.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery.
Marpai is an AI tech company revolutionizing the self-funded health plan
market representing over $1 trillion in health claims, $20 billion in
administrative fees, and 95 million Americans. Just as Netflix, Amazon,
Uber, and Tesla use artificial intelligence to transform and lead industry
sectors, Marpai (pronounced Mar-pay) is using deep learning, the most
advanced artificial intelligence, to transform health plan administration
for companies who self-fund their health plans. As a next-generation
TPA (Third Party Administrator) using SMART technology (deeplearning powered), Marpai’s mission is to save lives, improve lives, and
radically reduce the costs of healthcare for employers and plan
members.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
Bragg Gaming Group is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force. Formed by a team of gaming industry experts, Bragg's main portfolio asset is ORYX Gaming, an innovative business-to-business gaming technology platform and casino content aggregator. Through this brand and targeted acquisitions, Bragg is focused on becoming a leader within the evolving global gaming industry.
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how.
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class. The Company signed a multi-year distribution agreement for its COVID-19 Risk Test and remains on track to launch its revolutionary Multi-Test, covering up to 70% of mortalities and morbidities, including major oncological, metabolic, and degenerative diseases. Genetic Technologies recent acquisition of EasyDNA has significantly accelerated the Company’s commercialization strategy, providing established revenue streams and direct-to-consumer marketing channels that include 70 websites in 40 countries. Listed on the ASX in 2000 and NASDAQ in 2005, Genetic Technologies has been a leader in the development and commercialization of genetic risk assessment technology for 20 years.
Document Security Systems (DSS) is a multinational company operating businesses focused
on brand protection technology, blockchain security, direct marketing, healthcare, real estate,
and securitized digital assets. Its business model is based on a distribution sharing system in
which shareholders will receive shares in its subsidiaries as DSS strategically spins them out
into IPOs. Its historic business revolves around counterfeit deterrent and authentication
technologies, smart packaging, and consumer product engagement. DSS is led by its seasoned
leaders with decades of industry experience.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery.
Marpai is an AI tech company revolutionizing the self-funded health plan
market representing over $1 trillion in health claims, $20 billion in
administrative fees, and 95 million Americans. Just as Netflix, Amazon,
Uber, and Tesla use artificial intelligence to transform and lead industry
sectors, Marpai (pronounced Mar-pay) is using deep learning, the most
advanced artificial intelligence, to transform health plan administration
for companies who self-fund their health plans. As a next-generation
TPA (Third Party Administrator) using SMART technology (deeplearning powered), Marpai’s mission is to save lives, improve lives, and
radically reduce the costs of healthcare for employers and plan
members.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
Bragg Gaming Group is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force. Formed by a team of gaming industry experts, Bragg's main portfolio asset is ORYX Gaming, an innovative business-to-business gaming technology platform and casino content aggregator. Through this brand and targeted acquisitions, Bragg is focused on becoming a leader within the evolving global gaming industry.
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how.
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class. The Company signed a multi-year distribution agreement for its COVID-19 Risk Test and remains on track to launch its revolutionary Multi-Test, covering up to 70% of mortalities and morbidities, including major oncological, metabolic, and degenerative diseases. Genetic Technologies recent acquisition of EasyDNA has significantly accelerated the Company’s commercialization strategy, providing established revenue streams and direct-to-consumer marketing channels that include 70 websites in 40 countries. Listed on the ASX in 2000 and NASDAQ in 2005, Genetic Technologies has been a leader in the development and commercialization of genetic risk assessment technology for 20 years.
Document Security Systems (DSS) is a multinational company operating businesses focused
on brand protection technology, blockchain security, direct marketing, healthcare, real estate,
and securitized digital assets. Its business model is based on a distribution sharing system in
which shareholders will receive shares in its subsidiaries as DSS strategically spins them out
into IPOs. Its historic business revolves around counterfeit deterrent and authentication
technologies, smart packaging, and consumer product engagement. DSS is led by its seasoned
leaders with decades of industry experience.
1847 Holdings LLC (1847) seeks to provide non-correlated returns by combining the most attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company. 1847’s unique structure permits flow-through tax treatment for shareholders. As a result, 1847 will seek to generate returns for shareholders through consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries. 1847’s current portfolio includes Neese Inc., an agricultural industry services company with a 27-year operating history and growing market share in waste disposal services, and Goedeker’s, one of the top-30 largest appliance retailers in the country.
Draganfly has been a leader in the professional drone industry for
more than 20 years, supporting clients with enterprise drone
solutions, contract engineering services, custom software,
professional unmanned aerial vehicle (UAV) services, and
more. From public safety to pop culture, Draganfly has shaped not
just the UAV industry, but the way people around the world work and
live. Breaking ground with international firsts, Draganfly has a legacy
of leading the professional drone industry, including releasing the
first commercialized quadrotor UAV in 1999 and releasing the first
multirotor UAV with an integrated camera system in 2001. In 2013,
Draganflyer was credited as the world’s first small unmanned aerial
system (sUAS) to save a person’s life, and in 2016, Draganfly
became the first company to have multiple UAV systems deemed
Transport Canada Compliant.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
1847 Holdings LLC (1847) seeks to provide non-correlated returns by combining the most attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company. 1847’s unique structure permits flow-through tax treatment for shareholders. As a result, 1847 will seek to generate returns for shareholders through consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries. 1847’s current portfolio includes Neese Inc., an agricultural industry services company with a 27-year operating history and growing market share in waste disposal services, and Goedeker’s, one of the top-30 largest appliance retailers in the country.
Medalist Diversified REIT (NASDAQ: MDRR) is a public Virginia-based Real Estate Investment Trust specializing in acquiring, owning and managing value-add commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate. Learn more at MDRRinfo.com.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Wytec is a designer and developer of 5G networks and has developed intellectual property that can support the development and deployment of public and private 5G cellular networks. Wytec also partners with the world’s top technology providers in both inbuilding cellular and private LTE networks with a strong concentration in the educational industry.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Maris-Tech is a leading B2B provider of intelligent video transmission technology, founded by veterans of the Israel technology sector with extensive electrical engineering and imaging experience. Our products are designed to meet the growing demands of commercial and tactical applications, delivering high-performance, compact, low power and low latency solutions to companies worldwide, including leading electro-optical payload, RF datalink and unmanned platform manufacturers as well as defense, HLS, and communication companies.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
American International Holdings (AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses. Today, the AMIH portfolio encompasses telemedicine and other virtual health platforms, affordable subscriber-based primary care and concierge medicine plans, preventative care solutions and wellness related assets such as mental & behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH’s focus is on bringing to market technologies and solutions that advance the quality of life for the global community.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical and dental applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, virtually painless, and less expensive. Milestone’s proprietary DPS® Dynamic Pressure Sensing technology® platform advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for epidural space identification in regional anesthesia procedures.
DSS Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. DSS is led by its seasoned leaders with decades of industry experience.
1847 Holdings LLC (1847) seeks to provide non-correlated returns by combining the most attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company. 1847’s unique structure permits flow-through tax treatment for shareholders. As a result, 1847 will seek to generate returns for shareholders through consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries. 1847’s current portfolio includes Neese Inc., an agricultural industry services company with a 27-year operating history and growing market share in waste disposal services, and Goedeker’s, one of the top-30 largest appliance retailers in the country.
Draganfly has been a leader in the professional drone industry for
more than 20 years, supporting clients with enterprise drone
solutions, contract engineering services, custom software,
professional unmanned aerial vehicle (UAV) services, and
more. From public safety to pop culture, Draganfly has shaped not
just the UAV industry, but the way people around the world work and
live. Breaking ground with international firsts, Draganfly has a legacy
of leading the professional drone industry, including releasing the
first commercialized quadrotor UAV in 1999 and releasing the first
multirotor UAV with an integrated camera system in 2001. In 2013,
Draganflyer was credited as the world’s first small unmanned aerial
system (sUAS) to save a person’s life, and in 2016, Draganfly
became the first company to have multiple UAV systems deemed
Transport Canada Compliant.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
1847 Holdings LLC (1847) seeks to provide non-correlated returns by combining the most attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company. 1847’s unique structure permits flow-through tax treatment for shareholders. As a result, 1847 will seek to generate returns for shareholders through consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries. 1847’s current portfolio includes Neese Inc., an agricultural industry services company with a 27-year operating history and growing market share in waste disposal services, and Goedeker’s, one of the top-30 largest appliance retailers in the country.
Medalist Diversified REIT (NASDAQ: MDRR) is a public Virginia-based Real Estate Investment Trust specializing in acquiring, owning and managing value-add commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate. Learn more at MDRRinfo.com.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the Southeast for acquisition opportunities and disposal of properties as considered appropriate.
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
Newt is a cloud-based Software as a Service (SaaS) platform enabling enterprises to offer digital financial products and services. Digital financial technologies and infrastructure are reshaping payments, commerce, and access to financial services, creating a growing market opportunity for digital financial service disruptors like Newt.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Wytec is a designer and developer of 5G networks and has developed intellectual property that can support the development and deployment of public and private 5G cellular networks. Wytec also partners with the world’s top technology providers in both inbuilding cellular and private LTE networks with a strong concentration in the educational industry.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
Maris-Tech is a leading B2B provider of intelligent video transmission technology, founded by veterans of the Israel technology sector with extensive electrical engineering and imaging experience. Our products are designed to meet the growing demands of commercial and tactical applications, delivering high-performance, compact, low power and low latency solutions to companies worldwide, including leading electro-optical payload, RF datalink and unmanned platform manufacturers as well as defense, HLS, and communication companies.
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live. Breaking ground with international firsts, Draganfly has a legacy of leading the professional drone industry, including releasing the first commercialized quadrotor UAV in 1999 and releasing the first multirotor UAV with an integrated camera system in 2001. In 2013, Draganflyer was credited as the world’s first small unmanned aerial system (sUAS) to save a person’s life, and in 2016, Draganfly became the first company to have multiple UAV systems deemed Transport Canada Compliant.
American International Holdings (AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses. Today, the AMIH portfolio encompasses telemedicine and other virtual health platforms, affordable subscriber-based primary care and concierge medicine plans, preventative care solutions and wellness related assets such as mental & behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH’s focus is on bringing to market technologies and solutions that advance the quality of life for the global community.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical and dental applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, virtually painless, and less expensive. Milestone’s proprietary DPS® Dynamic Pressure Sensing technology® platform advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for epidural space identification in regional anesthesia procedures.
DSS Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. DSS is led by its seasoned leaders with decades of industry experience.
CPOs today are aggressively & proactively working towards defining the performance criteria that will be used to measure procurements contribution to business objectives. Savings being one of the key performance attributes linked to procurement, in this session Matthew Weinberg, Senior Manager from Cubist Pharmaceuticals will be sharing his insights into the approach adopted by Cubist to track and report on the savings generated through different sourcing initiatives.
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating diagnostic and therapeutic products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. With modest cash burn and a strong balance sheet, including $142.4 million cash and cash equivalents as of June 30, 2023, Zomedica is well-positioned to fund both organic growth and acquisitions.
Dócola is a social good organization with the only free care communication platform that consolidates thousands of free and low-cost patient education resources from the leading nonprofit, government, and commercial organizations in one marketplace. Plus, you can easily create and upload your own resources.
INNO HOLDINGS INC. is an innovative building-technology company with a mission to transform the construction industry with our proprietary cold-formed steel- framing technology and other building innovations
Everything Blockchain builds platforms of trust for the modern enterprise and is on a mission to ensure every organization has access to the tools and platforms that enable them to manage, store, and protect data without the cost and complexity that holds them back today. The Company’s patented advances in engineering deliver the essential elements needed for real-world business use: speed, security, and efficiency. Everything Blockchain’s current business lines include: EB Advise, Build DB and EB Control.
ASP Isotope is an isotope enrichment company utilizing technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses. Many of these elements are unsuitable for enrichment using traditional methods such as centrifuges. The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries.
MDNA Life Sciences is a pioneer in the science of mitochondrial DNA. It’s our mission to create an extensive portfolio of proprietary tests that dramatically improve diagnosis, treatment, prognosis and monitoring. Putting an end to the unnecessary surgical procedures, pain and uncertainty that affect patients across the world.
Digital Ally, Inc. is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. The Company pursues an acquisition strategy that targets organizations with positive earnings, strong growth potential, innovation, and operational synergies. To maximize long-term shareholder value, Digital Ally intends to spin-off its ticketing and entertainment business lines into a separate public company in 2023. The spin-off will create two optimized, tech-driven public companies with strong growth opportunities and operating metrics.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
Aditxt is a global innovation company focused on discovering and developing precision medicine innovations and deploying them into high-performing businesses. Aditxt’s diverse innovation portfolio includes: Adimune™, Inc., developing and designing a new class of therapeutics for retraining the immune system to address organ rejection, autoimmunity, and allergies; Adivir™, Inc., focused on identifying, developing and commercializing new ways to treat infectious diseases; and Pearsanta™, Inc., offering convenient, rapid, personalized, and high-quality lab testing —anytime and anywhere at its CLIA certified and CAP accredited clinical laboratory based in Richmond, VA.
1847 Holdings LLC, a publicly traded diversified acquisition holding company, was founded by Ellery W. Roberts, a former partner of Parallel Investment Partners, Saunders Karp & Megrue and Principal of Lazard Freres Strategic Realty Investors. EFSH's investment thesis is that capital market inefficiencies have left the founders and/or stakeholders of many small business enterprises and lower-middle market businesses with limited exit options, despite the intrinsic value of their business. Given this dynamic, EFSH can consistently acquire "solid" businesses for reasonable multiples of cash flow and then deploy resources to strengthen the infrastructure and systems to improve operations. These improvements may lead to a sale or IPO of an operating subsidiary at considerably higher valuations than the purchase price (as successfully demonstrated with the mid-2020 IPO of 1847 Goedeker on the NYSE American) and/or alternatively, an operating subsidiary may be held in perpetuity and contribute to EFSH's ability to pay regular and special dividends to shareholders.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The Company’s product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and is on track to launch this new product line in Q4 2023. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
SPI Energy is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions that was founded in 2006 in Roseville, California and is headquartered in McClellan Park, California. The Company has three core divisions: SolarJuice which has solar wholesale distribution, as well as residential solar and roofing installation and solar module manufacturing (Solar4America & SEM Wafertech), SPI Solar and Orange Power which operates a commercial & utility solar division, and the EdisonFuture/Phoenix Motor EV division. SolarJuice is the leader in renewable energy system solutions for residential and small commercial markets and has extensive operations in the Asia Pacific and North America markets. The SPI Solar commercial & utility solar division provides a full spectrum of EPC services to third party project developers, and develops, owns and operates solar projects that sell electricity to the grid in multiple regions, including the U.S., U.K., and Europe. Phoenix Motor is a leader in medium-duty commercial electric vehicles, and is developing EV charger solutions, electric pickup trucks, electric forklifts, and other EV products. SPI maintains global operations in North America, Australia, Asia and Europe and is also targeting strategic investment opportunities in fast growing green energy industries such as battery storage, charging stations, and other EVs which leverage the Company's expertise and substantial solar cash flow.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BullFrog AI is a technology enabled drug development company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University and J. Craig Venter Institute, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.
Lantern Pharma is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, our newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program.
Genetic Technologies is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GENE offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wines by the glass, SALT naturally flavored tequilas, Pulpoloco Sangria, and TapouT performance hydration and recovery drinks and TapouT Cognitive Energy Drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution.
Osisko Development - Investor Presentation - June 24
DSS Presentation Deck Dec 2021
1. DSS
2 0 2 1 Investor Presentation
Unlocking Value and
Delivering Shareholder
Returns with Holdings in
Growth Sectors
Worldwide
2. Forward Looking Statements
This presentation contains forward-looking statements that are made pursuant to the safe harbor provisions within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Such forward-looking statements include, but are not limited to, statements related to the Company's ability to
complete the financing, its intended use of proceeds and other statements that are not historical facts. Forward-looking
statements are based on management's current expectations and are subject to risks and uncertainties that may cause
actual results or events to differ materially from those projected. These risks and uncertainties, many of which are beyond
our control, include: risks relating to our growth strategy; our ability to obtain, perform under and maintain financing and
strategic agreements and relationships; risks relating to the results of development activities; our ability to attract,
integrate and retain key personnel; our need for substantial additional funds; patent and intellectual property matters;
competition; as well as other risks described in the section entitled "Risk Factors" in the prospectus and in our other filings
with the SEC, including, without limitation, our reports on Forms 8-K and 10-Q, all of which can be obtained on the SEC
website at www.sec.gov. Readers are cautioned not to place undue reliance on the forward-looking statements, which
speak only as of the date on which they are made and reflect management's current estimates, projections, expectations
and beliefs. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in our expectations or any changes in events,
conditions or circumstances on which any such statement is based, except as required by law.
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS 2
3. In 2019, we began a major transformation of a business concentrated entirely in the printing and packaging industry. Today, we take
ownership positions or fully acquire businesses in five high-growth sectors to monetize our holdings by;
1. Transitioning the company’s revenue streams into exponential and emerging new business lines
2. Operating the company to create growth opportunities and scalable/recurring revenue
3. Restructuring and Developing our assets to position them for growth and potential monetization
Our Strategy delivers shareholder value by;
1. Developing solid revenue growth, increasing profitability, growing assets which will drive stock price and market cap
2. Building long-term shareholder values by increasing assets through mergers and acquisitions
3. Providing a unique dividend structure to build value, and monetize assets for investors
APRIL
DSS appoints
board member
and turnaround
specialist Frank
Heuszel as CEO
2nd Half
DSS initiates new
business
strategies to
diversify revenues
and holdings
2019 2020
FEBRUARY
DSS reports
record Q1
2020
revenues
MARCH
LOI to acquire
Impact
BioMedical; plan
to spinout as IPO
MAY
Acquired
52% of
American
Medical
REIT
JULY
Premier signs
$6M/yr. multi-year
with one of the
world’s largest
retailers
JULY
Launched
AuthentiGuard as
a Service, early
adoption by global
PPE supplier
Transformation Milestones
AUGUST
Began
divesting
Plastics
Business and
wind down of
Technology
Management
AUGUST
Impact
BioMedical
Acquired
SEPTEMBER
Premier
signs
$9.6M/yr.
multi-year
contract with
top client
OCTOBER
Record Q3
$5.4M Net
Income, $1.20
per Share
JANUARY
Closes $24.0
Million Upsized
Public Offering
of Common
Stock
MARCH
Income From
Continuing
Operations
Increased $5.7
Million Y-o-Y
2021
About Us
3
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
MAY
DSS Sells its
Digital Division
to Proof
Authentication
Corporation
JUNE
DSS. Closes
$50 Million
Public
Offering
SEPTEMBER
DSS Invests
$40 Million
into American
Pacific
Bancorp
SEPTEMBER
Document
Security
Systems, Inc.
changes its
name to
DSS, Inc.
NOVEMBER
DSS Expands
American
Medical REIT
with
Acquisition of
3 Hospitals in
Texas and
Pennsylvania
FEBRUARY
DSS enters
into a JV
with
Coinstreet &
GSX to create
USX
4. DSS, Inc.
Price – Dec 3, 2021 .75 Shares Out 67.6M
Market Cap 80 M Float 57.4M
Avg. Daily Volume 1.95 M Inst. Ownership 30%
YE 2020 EPS 1.01 1y Target Price 13.75
A Diversified Portfolio Positioned to Drive Strong Cash Flow and Profitability
4
Investment Highlights
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
▪ Unique turn-around story with multiple revenue streams and created unique, co-monetization opportunity available to
shareholders upon IPO of a DSS holding
▪ 2021 YTD revenue of $13.2 million exceeds 2020 revenue 30%
▪ REIT acquired health facilities in Connecticut, Texas, and Pennsylvania valued at $68.4 million, generating its very first revenues
▪ DSS Launches AmericaFirst Quantitative Funds, a suite of 4 mutual funds managed by DSS Wealth Management, Inc.
▪ Near-term opportunity to spin out current holding – Impact BioMedical - in an IPO
▪ Grew 2020 revenues 12%, reversed ($2.6 M) net loss to $3.1 M in net income in 2020
▪ Zacks Research 2021 price target of $20.90 (based on 1.8 times EV to sales on trailing 12-month revenues)
5. DSS Invests $40 Million into American Pacific Bancorp, Inc.
American Pacific Bancorp (“APB”) acquires equity positions of commercial banks in the US and targets to inject digital
banking capabilities into the banks to provide global banking services to global clients and increase efficiency.
DSS makes a $40 million investment in APB acquiring over 50% of APB’s outstanding shares of common stock,
making DSS the majority-owner of APB.
APB has assembled a strong pipeline of diversified loans from home mortgages, licensed medical real estate
financing, district bonds, SME loans, convertible loans and profit participation loans.
5
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
Investment Highlights cont.
6. We Focus on Selected Growth Sectors
We have isolated five (5), high-growth sectors from which we identify companies to initiate an ownership position or
acquire businesses. Our sector focus is the backbone to DSS Groups and our holdings in each.
We Target Defined Business Criteria
The growth potential of these chosen sectors is global, allowing us to capitalize on a sector’s strength in particular
regions, like Asia. A checklist of performance and value-based criteria is used to assess potential holdings. Growth
opportunity, management team and companies’ untapped value is rated to our standards before we initiate an
ownership percentage or outright acquisition.
We Maintain Monetization Options
The experience of our management provide us the ability to monetize our positions by; operating a holding, selling a
holding or one of its assets, or financing future growth of a holding in an IPO. These options allow us to choose the most
profitable monetization option for our holdings and its benefit for DSS shareholders.
DIRECT-TO-CONSUMER (D2D)
SALES & MARKETING
BIO HEALTH SECURITIES & FUNDS
MANAGEMENT
BLOCKCHAIN &
FINTECH
RENEWABLE
ENERGY
DSS
MONETIZATION
STRATEGIES
1. OPERATE for Revenues
and Earnings
2. ENGAGE in Strategic Joint
Ventures and Licensing
Opportunities
3. IPO the company to capitalize
growth and value to
shareholders
6
Our Business Methodologies to Increase
Shareholder Value
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
7. Our transformation increased
year-over-year (2021 vs 2020):
Revenues
30%
Shareholder Equity
160%
1 DIRECT-TO-
CONSUMER (D2D)
SALES & MARKETING
2BIO HEALTH
3 SECURITIES &
FUNDS
MANAGEMENT
4 BLOCKCHAIN &
FINTECH
5 RENEWABLE
ENERGY
7
Acquired Businesses
Operate within
5 Revenue-Generating
Sectors
$127.2 Million
Total Assets
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
8. ▪ Direct-to-consumer (or D2C) companies manufacture and
ship their products directly to buyers without relying on
traditional stores or other middlemen. This allows companies
to sell their products at lower costs than traditional
consumer brands, and to maintain end-to-end control over
the making, marketing, and distribution of products.
▪ The market has been growing rapidly, with double-digit
rates for several years. It is projected to maintain a further
19.2% growth in 2021.
▪ In support of growth in D2C and other industries, consumer
packaging has also grown and is expected to surpass $1
Trillion by 2028.
▪ At the same time, counterfeit products are expanding at a
rapid rate, encompassing industries such as food and
beverages, chemicals, consumer electronics, automotive
components, medical devices and pharmaceuticals, and
agriculture.
▪ Authentication and brand protection market was valued at
$3.94 Billion in 2018 and is projected to reach $7.66 Billion by
2026, growing at a CAGR of 8.66% from 2019 to 2026. (Verified
Market Research, 2020).
8
1. Direct-to-Consumer (D2C)
Sales & Marketing
9. Creating a purpose-driven business model enabling home-based people in the new GIG economy with a growing list of product for direct-to-
consumer selling by individuals in the HWHWorld. Offers a large selection of; food, cosmetic and health product to HWH Direct Selling
associates.
RECENT DEVELOPMENTS
▪ Expanding business in Malaysia.
▪ Launched Over-30 and Immune Shield.
▪ Routinely adding new products.
Sharing Services’ (OTCQB:SHRG) combined platform leverages the capabilities and expertise of various companies that market and sell
products direct to the consumer through independent brand partners and e-commerce. Technology, eCommerce platforms, and gig
economy opportunities are targeted for acquisition, new business development, and management.
RECENT DEVELOPMENTS
▪ Sharing Services Global to Offer ‘Passport to Happiness’ Amid Expected Travel Boom.
▪ Sharing Services to Unveil New, Distinct Travel Service.
▪ Secured Direct Selling License in South Korea.
▪ DSS Strengthens Its Interest in Sharing Services Global Corporation through $30 Million Investment.
Industry Direct-to-Consumer Sales HQ Dallas, TX USA Ownership 48% DSS Monetization Strategy ✓ OPERATE for Revenue Generation
9
Direct-to-Consumer | D2C Sales & Marketing
Group Holdings
D2C Operations Combined with the Sector’s Product Packaging Requirements
Industry D2C Sales HQ Dallas, TX USA Ownership 100% DSS Monetization Strategy ✓ OPERATE for Revenue Generation
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
10. Innovative designs deliver functionality, marketability, sustainability, and anti-counterfeiting technology. When paired with our
portfolio of digital solutions and technologies, Premier can provide brand solutions that revolutionize the active and intelligent
packaging space.
Industry Consumer Packaging HQ Victor, NY USA Ownership 100% DSS Monetization Strategy ✓ OPERATE for Revenue Generation
RECENT DEVELOPMENTS
▪ Expanded Operations with 105,000 Sq. Ft. Facility to Meet Growing Demand.
▪ Packaging, printing and fabrication grew 27% year over year and is now operating at full capacity given its own capabilities,
combined with its ability to source components.
▪ Sold out for the rest of 2021 and through the beginning of 2022.
▪ Signed Global Personal Protective Equipment (PPE) Exporter as an Early Adopter of The Company's New AuthentiGuard as a
Service (AgaaS) Anti-counterfeiting Technology.
▪ Signed Multi-Year Contract Valued at $3.2 Million Per Annum with One Of World’s Largest Photography and Image Sharing
Companies; Total Contract Valued at Nearly $10 Million.
▪ Continued access to DSS world class consumer engagement and product authentication technologies.
10
Direct-to-Consumer | D2C Sales and Marketing
Group Holdings
D2C Operations Combined with the Sector’s Product Packaging Requirements
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
11. ▪ Bio Health is the intersection of healthcare, life sciences,
biosciences, digital health, and biomanufacturing – a
combined market of $1.3 T (The Korea Times, 2021).
▪ Bio Health is a rapidly expanding cluster of industries, with
over 1900 bio health companies across the state and 107,616
direct jobs in the bio health industry. (University of Wisconsin,
Madison).
▪ South Korea, a leader in the bio health sector, announced a
$9.0B investment plan for the bio health industry for 36
pharmaceutical makers and five venture capital firms,
including Samsung Biologics Co. and Celltrion Inc.
▪ US states cite bio health growth:
▪ Wisconsin’s bio health industry is outperforming most major
state industries in terms of job growth and
wages. (TECnomy Partners, 2021).
▪ The bio health industry is one of the most important within
Maryland’s high-tech economy - collectively, the industry
has an average annual wage that is over $98,961 (2018 BIO
Industry Report).
11
2. Healthcare’s Future is
Focused on Bio Health
12. Research and development that advances drug discovery and development for the prevention, inhibition, and treatment of
neurological, oncology and immuno-related diseases. Other exciting technologies include breakthrough alternative sugar in the aim to
combat diabetes and Functional Fragrances Formulation (3F) for industrial and medical application, amongst others. The first product in
3F’s suite of functional fragrances is 3F Mosquito which is made up of specialized oils sourced from botanicals that mosquitoes avoid.
The business model of Impact Biomedical revolves mainly around two methodologies – Licensing and Sales Distribution.
Industry Bio Health HQ Winter Haven, FL USA Ownership 100% DSS Monetization Strategy ✓ IPO
RECENT DEVELOPMENTS
▪ DSS Expands Nutraceutical Product Lines through Impact BioMedical’s Investment in Nano Nutraceutical Contract Manufacturer Nano9.
▪ Impact BioMedical Receives Notice of Allowance for 3F Biofragrance Patent.
▪ Impact BioMedical Announces Exclusive Distribution Agreement with BioMed Technology.
Functional Fragrance
Formulation (3F)
A suite of functional fragrances
developed for industrial and
medical applications
Pandemic Research
A patented OTC
medication with broad
antiviral activity
Linebacker Platform
Broad-spectrum universal
therapeutic platform
Laetose Alternative Sugar
Natural functional sugar
10+ Product Portfolio, some are:
12
Bio Health Group Holdings
Drug Discovery and Prevention, Inhibition, and Treatment of Neurological, Oncological, Immune-related Diseases and
Transmission of Air-borne Infectious Diseases
Gut Health Product Bacterial, Viral and
antimicrobial Protection
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
13. ▪ Rising vacancy rates, falling rents Commercial real estate
markets overall have suffered from the pandemic and
recession, but with considerable variation across the property
types, geographies and quality of the property. Vacancy rates
have increased in 2020 for most property types.
▪ Office vacancies are still well below the 13.1% reached in 2010,
but experience in past recessions suggests that vacancy rates
will continue to rise through 2021 and perhaps reach a peak
only in early 2022.
▪ Despite relatively strong demand for logistics space used to
ship goods bought on the internet, the elevated pace of
construction resulted in higher vacancies.
▪ Retail markets in many ways are the flip side of industrial:
demand for industrial continues to rise, but new supply has
exceeded demand in 2020, while demand for retail properties
is quite weak, but new construction has been minimal.
▪ Hospitals, clinics, and doctors’ offices aren’t filling up to pre-
pandemic levels. But with health services getting back to
normal, demand for medical real estate is holding steady.
Landlords say rents are being collected at nearly 100% of pre-
Covid-19 levels. Acquisitions are ramping up, and interest
rates remain low—conditions that should fuel dividend and
asset growth.
13
3.The Post-Pandemic
Opportunity
14. Industry Real Estate Location Nashville, TN USA Ownership 100% DSS Monetization Strategy ✓ OPERATE for Revenue Generation
RECENT DEVELOPMENTS
▪ Several letters of intent out for various properties.
▪ Aggressive Pipeline.
AAMI/AARE
AAMI is a medical real estate investment trust (“REIT”) management company that sets the strategic vision and formulates investment
strategy for AMRE. It manages the REIT’s assets and liabilities and provides recommendations to AMRE on acquisition and divestments in
accordance with the investment strategies. American Medical REIT, Inc. is a Maryland corporation, organized for the purposes of
acquiring hospitals and other acute or post-acute care centers from leading clinical operators with dominant market share in secondary
and tertiary markets, and leasing each property to a single operator under a triple-net lease. AMRE was formed to originate, acquire, and
lease a credit-centric portfolio of licensed medical real estate. AMRE is planned to qualify as a Real Estate Investment Trust for federal
income tax purposes, which will provide AMRE’s investors the opportunity for direct ownership of Class A licensed medical real estate.
14
Securities & Fund Management
A Fast-Growing Market of Medical Building and Sustainable Housing is the Target of Our Real Estate and
REIT Holdings
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
15. ▪ A blockchain supply chain can help participants record price,
date, location, quality, certification, and other relevant
information to more effectively manage the supply chain. The
availability of this information within blockchain can increase
traceability of material supply chain, lower losses from
counterfeit and gray market, improve visibility and
compliance over outsourced contract manufacturing, and
potentially enhance an organization's position as a leader in
responsible manufacturing. (Deloitte Perspectives, 2021).
▪ The global blockchain market size is expected to grow from
$3.0 billion in 2020 to $39.7 billion by 2025, at a compound
annual growth rate (CAGR) of 67.3% during 2020–2025.
▪ Increasing need for simplifying the business processes and
need for supply chain management applications integrated
with the blockchain technology and Fintech will drive the
overall market.
15
4.Blockchain & Fintech
Technologies are
Transformative
17. ▪ Market was estimated at $1.1 Billion in 2019 and is expected to
reach $2B by 2025. The global renewable energy market is
expected to grow at a compound annual growth rate (CAGR) of
8.3% from 2019 to 2026.
▪ In 2020, annual renewable capacity additions increased 45% to
almost 280 GW – the highest year-on year increase since 1999.
▪ Exceptionally high-capacity additions become the “new normal”
in 2021 and 2022, with renewables accounting for 90% of new
power capacity expansion globally.
Top 5
Countries
Global
Share
10-Yr. Annual
Growth Rate
China 22.9% 33.4%
US 20.1% 10.1%
Germany 7.3% 9.3%
Brazil 7.0% 9.9%
India 4.2% 17.1%
2020 Renewable Energy Leaders
17
5. The Future of Renewable
Energy is Happening Today
18. Industry Sustainable Living Location Houston, TX USA Ownership 100% DSS Monetization Strategy ✓ OPERATE for Revenue Generation
Alset Solar purposes utility-scale solar farms to serve US regional power grids and to provide underutilized properties with small
microgrids for independent energy. Alset Energy will also look at other alternative energy opportunities for investment and
development. Our goal is to be a powerful force in the mitigation of the negative effects of climate change by reducing air pollution
and expanding access to clean energy for all, while contributing to global economic well-being.
Industry Solar Energy Location Houston, TX USA Ownership 100% DSS Monetization Strategy ✓ OPERATE for Revenue Generation
RECENT DEVELOPMENTS
▪ Alset Solar to Develop Utility-Scale Solar Farms at Superfund Sites and Other Underutilized Properties.
▪ ADD: Alset e-Home / Alset solar news.
A plan for fully sustainable, secure, and healthy living communities with homes incorporating advanced technology, energy
efficiency, and quality of life living environments both for new construction and renovations for single and multi-family residential
housing. Secure Living is currently working with several land development partners to develop entire fully sustainable, healthy living
single-family subdivisions.
RECENT DEVELOPMENTS
▪ DSS Launches DSS PureAir, Inc. and Makes Investment into Innovative Proactive Air and Surface Purification Solutions Technology from
Puradigm LLC.
SECURELIVING
18
Renewable Energy Group Holdings
Clean Energy with a Focus on Environmental Responsibility and Sustainability
SOLAR
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
19. 19
Summary of DSS Group Holdings
Companies / Holdings % Ownership Monetization Strategy
DIRECT-TO-CONSUMER SALES (D2C) Group
HWH WORLD 100% Revenue Generation
SHARING SERVICES 48% Revenue Generation
PREMIER 100% Revenue Generation
DSS DIGITAL 100% Sold on May 11, 2021
BIO HEALTH Group
IMPACT BIOMEDICAL 100% IPO Announced
REAL ESTATE AND REIT Group
US MEDICAL 100% Revenue Generation
AMERICAN MEDICAL REIT 100% Revenue Generation
RENEWABLE ENERGY Group
ALSET ENERGY 100% Revenue Generation
DIGITAL ASSET SECURITY Group
DSS ASSET MANAGEMENT 100% Revenue Generation
USX HOLDINGS 70% Revenue Generation
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
20. Frank D. Heuszel, Chief Executive Officer
Mr. Heuszel served as Chief Executive Officer and Interim Chief Financial Officer since April 2019 and has held a role on the board of
directors since July 2018. As Chief Executive Officer and Interim Chief Financial Officer, Heuszel is responsible for managing the
strategic direction, growth, day-to-day operations and governance of DSS. Prior to DSS, Heuszel spent 35years at Compass Bank
(now BBVA Compass) and Patriot Bank including C-Suite roles of General Counsel and Chief Financial Officer. In 2015, Heuszel
established The Law Offices of Frank D. Heuszel. Heuszel received his bachelor’s degree in business from the University of Texas at
Austin and his juris doctorate from the South Texas College of Law.
Jason T. Grady, Chief Operating Officer | President, Premier Packaging Corporation
Mr. Grady has served as Chief Operating Officer since July 2019. As Chief Operating Officer, Grady manages operations of 9 business
lines and 25 subsidiaries, advising the direction of each of the company’s newly formed subsidiaries, and the research and
development of emerging market opportunities across diverse business operations. Grady joined DSS in July 2010 and previously
served as Vice President of Sales and Marketing prior to becoming President, Premier Packaging Corporation in August 2018, a
position he still holds. Before joining DSS, Grady served as Director, Business Development at Berlin Packaging and Vice President of
Marketing at Parlec, Inc. Grady earned a bachelor’s degree and MBA from the Rochester Institute of Technology.
Todd D. Macko, Interim Chief Financial Officer
Mr. Macko joined DSS in January 2019 and previously served as Vice President of Finance of Premier Packaging Corporation, a
wholly-owned subsidiary of DSS, and VP, Finance, DSS prior to his promotion to Interim Chief Financial Officer in October 2020. In
August 2021, Macko was promoted to CFO. As CFO, Macko leads finance across DSS and its divisions in all aspects of financial and
strategic planning, capital budgeting, investor relations, competitive analysis, cost reduction analysis, and board of director’s
support. Prior to DSS, Macko spent his career in public and corporate financial management, most recently serving as Corporate
Controller for Baldwin Richardson Foods. Heearned a Bachelor of Science in Accounting from Rochester Institute of Technology.
Heng Fai Ambrose Chan, Executive Chairman of the Board
An accomplished global business veteran of more than 40 years Mr. Chan Heng Fai specializes in financial restructuring and
corporate transformation to unlock value and unleash entrepreneurial zeal while managing risk. He has successfully restructured
more than 35 corporations in different industries and countries. Mr. Chan has served as a director of the Company since February
2017 and became Chairman of the Board of Directors in March 2019. He has also served as an officer of the Company’s wholly-owned
subsidiary, DSS since July 2017. His expertise in banking and finance combined with his international business contacts qualify him
to serve on our Board of Directors.
20
Our Team of Experienced Operators
DELIVERING SHAREHOLDER VALUE WITH HOLDINGS IN GROWTH SECTORS
21. DELIVERING SHAREHOLDER VALUE WITH
HOLDINGS IN GROWTH SECTORS
Investor Contact:
Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
Dave@redchip.com
Contact Us
21